Oxidation of alpha 1-protease inhibitor: role of lipid peroxidation products.
Previously we demonstrated that in vivo exposure of humans to NO2 resulted in significant inactivation of alpha 1-protease inhibitor (alpha 1-PI) in the bronchoalveolar lavage fluid. However, alpha 1-PI retains its elastase inhibitory activity in vitro when exposed to 10 times the concentration of NO2 used in vivo. We suggested exogenous oxidants such as O2 and NO2 exert their effect in vivo in part through lipid peroxidation. We investigated the mechanism of inactivation of alpha 1-PI in the presence or absence of lipids under oxidant atmosphere. alpha 1-PI in solutions containing phosphate buffer (control), 0.1 mM stearic acid (saturated fatty acid, 18:0), or 0.1 mM linoleic acid (polyunsaturated fatty acid, 18:2) was exposed to either N2 or NO2 (50 ppm for 4 h). Elastase inhibitory capacity of alpha 1-PI was significantly diminished in the presence of 0.1 mM linoleic acid and under NO2 atmosphere (75 +/- 8% of control, P less than 0.01), whereas there was no change in elastase inhibitory capacity of alpha 1-PI in the presence or absence (buffer only) of 0.1 mM stearic acid under a similar condition (109 +/- 11 and 94 +/- 6%, respectively). The inactivated alpha 1-PI as the result of peroxidized lipid could be reactivated by dithiothreitol and methionine sulfoxide peptide reductase, suggesting oxidation of methionine residue at the elastase inhibitory site. Furthermore the inhibitory effect of peroxidized lipid on alpha 1-PI could be prevented by glutathione and glutathione peroxidase and to some extent by alpha-tocopherol.
Mohsenin
V
V
John B. Pierce Foundation Laboratory, Yale University School of Medicine, New Haven, Connecticut 06519.
Gee
J L
JL
D000975:Antioxidants / Q000494:pharmacology*; D001798:Blood Proteins / Q000378:metabolism*; D004229:Dithiothreitol / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000494:pharmacology; D008051:Lipid Bilayers; D015227:Lipid Peroxidation; D008054:Lipid Peroxides / Q000097:blood*; D008274:Magnesium / Q000494:pharmacology; D015636:Magnesium Chloride; D051150:Methionine Sulfoxide Reductases; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000378:metabolism; D010196:Pancreatic Elastase / Q000037:antagonists & inhibitors; D011480:Protease Inhibitors / Q000378:metabolism*; D013229:Stearic Acids / Q000494:pharmacology; D000515:alpha 1-Antitrypsin
D000975:Antioxidants; D001798:Blood Proteins; D008041:Linoleic Acids; D008051:Lipid Bilayers; D008054:Lipid Peroxides; D011480:Protease Inhibitors; D013229:Stearic Acids; D000515:alpha 1-Antitrypsin; D015636:Magnesium Chloride; C031183:stearic acid; D019787:Linoleic Acid; D010088:Oxidoreductases; D051150:Methionine Sulfoxide Reductases; C027219:methionine sulfoxide reductase; D010196:Pancreatic Elastase; D008274:Magnesium; D004229:Dithiothreitol